MariMed Inc. · CSE:MRMD
MariMed — Q3 2026 Earnings Presentation
21 slides from MariMed's earnings presentation, November 2026
Slide 1: Investor Presentation with Q3 2026 Financial Highlights
INVESTOR PRESENTATION WITH Q3 2026 FINANCIAL HIGHLIGHTS
Slide 2: Forward Looking Statement Disclaimer
Forward Looking Statement Disclaimer CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION: This presentation includes information, statements, beliefs, and opinions which are forward-looking, and which reflect current estimates, expectations, and projections about future events, referred to herein
Slide 3: We're on a Mission to Improve Lives Through the Power of Cannabis
We’re on a Mission to Improve Lives Through the Power of Cannabis. 3
Slide 4: Our Growth Strategy
OUR GROWTH STRATEGY • Grow MariMed’s portfolio • Expand wholesale • Increase customer lifetime of leading cannabis brands penetration and asset-light value through retail Scale Distribution through innovation, market expansion through engagement, loyalty Expand the Brand Deepen Consumer category exp
Slide 5: MariMed by the Numbers
MARIMED BY THE NUMBERS $160M 900+ 8 14 2025 REVENUE EMPLOYEES STATES DISPENSARIES inc. footprint + licensing partnerships 7 52M+ 720+ 5 FACILITIES Cultivation and POPULATION WHOLESALE BRANDS Production ACCOUNTS #1 Edible & #4 Beverage Across Core States ~510K+ sq ft (inc. PA facility under Mgmt.) ~$
Slide 6: Footprint & Portfolio of Assets
FOOTPRINT & PORTFOLIO OF ASSETS 3 190K 2 2 107K 2 180K 5 33K Number of dispensaries Cultivation & Processing (sq ft) 6
Slide 7: Why MariMed Wins
WHY MARIMED WINS Leading Cannabis CPG Platform Scalable Wholesale Engine Retail + Loyalty Ecosystem • #1 edible brand across core markets • 64% dispensary penetration • 432K loyalty members • Expanding beverage leadership • 720+ wholesale accounts • 80% of retail revenue tied to members • Portfolio
Slide 8: Wholesale: Driving Our Brand Momentum
WHOLESALE: DRIVING OUR BRAND MOMENTUM STRONG PERFORMANCE • Wholesale accounted for 44% of 3Q 2026 revenue BRAND PENETRATION • 64% penetration across core states during 3Q 2026 • Brand portfolio market share grew 150 bps STRATEGIC DISTRIBUTION • Product placements in 720+ dispensaries across 6 states
Slide 9: A Portfolio of Top-Selling Brands
A PORTFOLIO OF TOP-SELLING BRANDS* • Betty’s Eddies™ - #1 edible in MA, MD & DE • Bubby’s Baked™ - #1 baked goods edible in MA, MD & IL • Vibations™ Drink Mix – Top 10 beverage in MA, MD & IL • InHouse™ – Top 10 gummy in MA, MD & DE • Nature's Heritage™ - #1 flower brand in DE *based on BDSA and Lit
Slide 10: Continuing to Expand Across Core Markets
CONTINUING TO EXPAND ACROSS CORE MARKETS Wholesale Revenue (in millions USD) Doors Coverage Ratio $69.6 $80.0 800 Growth Rate 692 $70.0 $62.9 700 620 $60.0 600 $48.8 $50.0 500 410 $40.0 $32.9 400 $30.0 300 $20.0 200 $10.0 100 $0.0 26% 48% 29% 11% - 55% 83% 85% 2022 2023 2024 2025 2023 2024 2025 85%
Slide 11: Strong Retail Experience
STRONG RETAIL EXPERIENCE STRONG RETAIL BRAND & PRESENCE • 14 dispensaries across MA, IL, MD, DE, and OH • Strong presence under unified Thrive retail brand, app, and website CONSUMER EXPERIENCE • Curated, wellness-focused retail environments with premium design • Deep community engagement with veter
Slide 12: Strong Loyalty Member Growth
STRONG LOYALTY MEMBER GROWTH Series1 Members (‘000’s) Series2 Growth 500 450 415 432 Data-Driven Personalization Delivered: 402 400 364 • Membership +31% year to date growth 350 through Q3 2026 300 • Drove 80% of retail revenue in Q3 2026 250 • 1% higher avg basket vs non-members 200 in Q3 2026 150
Slide 13: Management Team
MANAGEMENT TEAM Jon Levine Timothy Shaw Howard Schacter CEO & President Chief Operating Officer Chief Communications Officer Co-founder of MariMed with two Oversees all cultivation, production, and Veteran communications leader with decades in the cannabis industry. Led retail operations across 9 st
Slide 14: Our Results: Q3 2026 Financial Performance
OUR RESULTS: Q3 2026 FINANCIAL PERFORMANCE
Slide 15: Q3 2026 Financial Results
Q3 2026 FINANCIAL RESULTS Revenue & Brand Momentum • Revenue increased 8% year over year to $44.2 million, Revenue $44.2 million despite ongoing industry pricing pressure across several core markets • Wholesale revenue grew 8% year over year, representing GAAP Gross Margin 38.8% 44% of total revenue
Slide 16: Balance Sheet - End of Q3 2026
BALANCE SHEET - END OF Q3 2026 Capital Structure • Total assets of $198.3 million versus total liabilities of $151.3 million as of quarter-end Cash and Cash Equivalents $10.4 million • Total debt of $78.2 million represented approximately 39% of total assets • Balance sheet capacity continues to sup
Slide 17: Q3 2026 YTD Cash Flow
Q3 2026 YTD CASH FLOW Cash Flow Category Q3 2026 YTD Activity Positive cash flow Operating Activities $6.654 million from operations Capital expenditures and license Investing Activities -$1.555 million renewals/purchases ~$3.5 million in scheduled Financing Activities -$3.622 million debt and finan
Slide 18: Year-end Non-GAAP Supplemental Information
Year-end Non-GAAP Supplemental information Income (loss) from Operations to Adjusted EBITDA Reconciliation (in ‘000s USD) 2020 2021 2022 2023 2024 2025 Income (loss) from operations 14,440 26,535 19,879 14,269 2,609 (2,820) Depreciation of property and equipment 1,792 2,098 3,432 5,549 7,910 8,109 A
Slide 19: Q3 2026 Non-GAAP Supplemental Information
Q3 2026 Non-GAAP Supplemental information (in ‘000s USD, except where noted) GAAP Income from operations 1,221 Depreciation of property and equipment 2,201 Amortization of acquired intangible assets 717 Stock-based compensation 335 Acquisition-related and other 183 Adjusted EBITDA 4,657 GAAP income
Slide 20: Q3 2026 Non-GAAP Supplemental Information
Q3 2026 Non-GAAP Supplemental information (in ‘000s USD, except where noted) GAAP Net loss (3,487) Stock-based compensation 335 GAAP Gross margin 38.8% Amortization of acquired intangible assets 717 Severance -- Amortization of acquired 1.2% Acquisition-related and other 183 intangible assets Non-GA
Slide 21: Thank You
THANK YOU For more information: Email: ir@marimedinc.com